Fate Therapeutics, Inc. ( FATE) - Key Metrics
FATE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.27 | -$0.20 | -$0.21 |
| 2025Q3 | $0.01 | -$0.27 | -$0.20 | -$0.22 |
| 2025Q2 | $0.02 | -$0.29 | -$0.21 | -$0.22 |
| 2025Q1 | $0.01 | -$0.32 | -$0.29 | -$0.30 |
FATE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.90 |
| 2025Q3 | ? | -1.16 |
| 2025Q2 | ? | -0.97 |
| 2025Q1 | ? | -0.62 |
FATE
Price: $2.41
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.6 million
Ebitda: -10.1 millionMarket Capitalization: 340.4 million